HealthCare Global Enterprises Limited , India's largest cancer care provider operating under the brand "HCG", has announced two key investor events surrounding its audited financial results for the quarter and financial year ended March 31, 2026. The company's Board of Directors is scheduled to meet on Tuesday, May 19, 2026, to consider and approve the audited financial results — both standalone and consolidated. Following the board meeting, an Earnings Conference Call has been scheduled for Wednesday, May 20, 2026, at 1:30 pm IST, to discuss the declared financial results with investors and analysts. The intimation has been filed under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Meeting and Earnings Call Details

The following table summarises the key details of both the board meeting and the earnings conference call:

Earnings Conference Call

The earnings conference call will be led by the senior management of HealthCare Global Enterprises Limited. The call will commence with a brief management discussion on the Q4 & FY26 results, followed by an interactive Question & Answer session for investors and analysts. Participants can pre-register via the provided link to connect without waiting for an operator. For updates and specific queries, investors may visit www.hcgel.com or write to investors@hcgoncology.com . Investors may also reach out to CDR India — Anoop Poojari at +91 98330 90434 / anoop@cdr-india.com or Suraj Digawalekar at +91 98211 94418 / suraj@cdr-india.com .

Trading Window Closure

In accordance with the company's code of conduct framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the company has been closed for all designated persons and their immediate relatives. The closure period commenced on April 1, 2026, and shall remain closed until 48 hours after the declaration of the financial results.

About HealthCare Global Enterprises Limited

HealthCare Global Enterprises Limited, headquartered in Bengaluru, is the largest provider of cancer care in India. Through its network of 25 hospitals across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG's comprehensive cancer centres provide expertise and advanced technologies for the effective diagnosis and treatment of cancer under one roof. The company also has a presence in the fertility segment under the "Milann" brand. The company's official website is available at https://www.hcgoncology.com/ .

HealthCare Global Enterprises Limited has announced the opening of a special window for transfer and dematerialization of physical securities, providing shareholders with a one-year opportunity to process their physical share holdings. This initiative represents a significant regulatory compliance measure following recent SEBI guidelines.

Special Window Details

The special window will remain operational from February 05, 2026 to February 04, 2027, spanning exactly one year. This facility has been established in accordance with SEBI circular no. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. The window specifically caters to physical securities that were sold or purchased prior to April 01, 2019.

Eligibility Criteria

The company has provided clear guidelines regarding eligibility for lodgement during this special window:

Processing Requirements

Requests submitted during the special window must include original certificate(s) along with transfer deeds and relevant supporting documents. All securities transferred through this facility will be mandatorily credited to transferees in demat mode only. Additionally, these transferred securities will remain in lock-in for one year from the transfer registration date, during which they cannot be transferred, pledged, or encumbered.

Shareholder Assistance

Shareholders wishing to avail this opportunity are requested to contact KFin Technologies Limited, the company's Registrar and Share Transfer Agent. The registrar can be reached at inward.ris@kfintech.com or through the toll-free number 1800-309-4001. KFin Technologies Limited is located at Selenium Tower-B, Plot No. 31 and 32, Financial District, Nanakramguda, Serilingampally Mandal, Hyderabad, Telangana, India - 500032.

Regulatory Compliance

HealthCare Global Enterprises Limited has fulfilled its regulatory obligations by publishing newspaper advertisements in Business Standard (English) and Vijayawani (Kannada) as required under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's stock codes are BSE – 539787 and NSE – HCG. Additional information regarding this special window is available on the company's website at https://www.hcgoncology.com/ .